ArticleEsophagus : official journal of the Japan Esophageal Society2026
Respiratory sarcopenia defined by paraspinal muscle mass and peak expiratory flow predicts postoperative pneumonia after esophagectomy for esophageal cancer: a comparison with sternocleidomastoid muscle mass.
Article in Esophagus : official journal of the Japan Esophageal Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia is a predictor of postoperative pneumonia after esophagectomy. Recently, respiratory sarcopenia has been proposed as a predictor of postoperative pneumonia that captures respiratory vulnerability more directly than sarcopenia. Respiratory sarcopenia is defined by decreased respiratory muscle strength (RMS) and respiratory muscle mass (RPM). As RPM does not have an established assessment method, previous studies used skeletal muscle mass at L3, including the psoas major (PM) and paraspinal (PS) muscles. However, this may not accurately reflect respiratory muscle status. Therefore, we focused on the sternocleidomastoid (SCM) muscle, an accessory respiratory muscle. We investigated which muscle mass measure for defining respiratory sarcopenia shows the strongest association with postoperative pneumonia after esophagectomy: SCM at C3, PM at L3, or PS at L3.
methodsWe reviewed 500 patients who underwent radical subtotal esophagectomy from 2007 to 2024. Based on preoperative CT, muscle mass was calculated as the areas of the three muscles normalized by height squared. RMS was assessed by percent predicted peak expiratory flow (%PEF). Respiratory sarcopenia was defined as low %PEF and low muscle mass. Univariable and multivariable logistic regression evaluated factors associated with postoperative pneumonia.
resultsEighty patients (16.0%) developed postoperative pneumonia. In multivariable analysis, respiratory sarcopenia defined by PS mass was associated with postoperative pneumonia after adjustment for covariates (OR: 2.76, 95% CI 1.32-5.79, P = 0.007). SCM- and PM-based definitions were not significantly associated with postoperative pneumonia.
conclusionRespiratory sarcopenia defined by decreased %PEF and PS mass is associated with postoperative pneumonia after esophagectomy.
Indexed as
Identifiers
42763381What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.